India, Nov. 24 -- The Government of India has issued a release:
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) today inaugurated a five-day Capacity Building Training Program for stakeholders engaged in the regulatory, academic, quality control, and manufacturing domains of Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) medicines. The specialized program, scheduled from November 24 to November 28, 2025, is designed to strengthen the knowledge and skills of drug regulators, enforcement authorities, quality control personnel, technical experts, government analysts, researchers, and scientists dedicated to ASU&H drug development and quality assurance.
Dr. Preetha Kizhakkutil, Advisor (Homoeopathy), Ministry of Ayus...